Nanoparticles for brain delivery of drugs or contrast agents. Application to Alzheimer's disease;Nanoparticules pour la délivrance cérébrale de principes actifs ou d'agents de contraste. Application à la maladie d'Alzheimer

Biologie Aujourd'hui

Volumn 206, Issue 3, 2012, Pages 185-190

  Andrieux, Karine ^a   Couvreur, Patrick ^a  

^a UNIVERSITÉ PARIS SACLAY   (France)

Author keywords

amyloid peptide; Alzheimer's disease; Blood brain barrier; Brain delivery; Nanoparticles

Indexed keywords

AMYLOID BETA PROTEIN; DRUG CARRIER; NANOPARTICLE;

ALZHEIMER DISEASE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN DISEASE; EUROPE; HUMAN; METABOLISM;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; BLOOD-BRAIN BARRIER; BRAIN DISEASES; DRUG CARRIERS; EUROPE; HUMANS; NANOPARTICLES;

EID: 84870022248     PISSN: 21050678     EISSN: 21050686     Source Type: Journal    
DOI: 10.1051/jbio/2012019     Document Type: Article

References (4)

1. Andrieux K., Desmäele D., D'Angelo J., Couvreur P., Nanotechnologies et nouveaux ḿedicaments, Actu Chim, 2003, 269-270, 135-139
2. Brambilla D., Le Droumaguet B., Nicolas J., Hashemi S.H., Wu L.-P., Moghimi S.M., Couvreur P., Andrieux K., Nanotechnologies for Alzheimer's disease: diagnosis, therapy, and safety issues. Nanomed Nanotechnol Biol Med, Nanomedicine, 2011, 7, 521-540
3. Garcia-Garcia E., Andrieux K., Gil S., Couvreur P., Colloidal carriers and Blood Brain Barrier (BBB) translocation: a way to deliver drugs to the brain? Int J Pharm, 2005, 298, 274-292
4. Karatas H., Aktas Y., Gursoy-Ozdemir Y., Bodur E., Yemisci M., Caban S., Vural A., Pinarbasli O., Capan Y., Fernandez-Megia E., Novoa-Carballal R., Riguera R., Andrieux K., Couvreur P., Dalkara T., A Nanomedicine Transports a Peptide Caspase-3 Inhibitor across the Blood-Brain Barrier and Provides Neuroprotection. J Neurosci, 2009, 29, 13761-13769. www.nadproject.eu ; www.AlzheimerEurope.org